Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Tianlong Pharmaceutical is a Chinese biopharmaceutical company focused on the development, manufacturing, and commercialization of recombinant protein drugs and small molecule therapeutics. The company is best known for its production of recombinant human interferon alpha-2b, which is used to treat viral infections such as Hepatitis B and C, as well as certain types of cancer. Shanghai Tianlong operates integrated facilities that cover the entire value chain from research and development to large-scale GMP manufacturing. Its product portfolio primarily targets infectious diseases, oncology, and metabolic disorders within the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Tianlong Pharmaceutical.